Eight IPOs raised $2.3 billion this past week. High-growth consumer deals Fitbit and Fogo de Chão came out on top. This week featured a diverse set technology, consumer, energy, health care and industrial IPOs, none of which priced...read more
Cynapsus Therapeutics, which is developing an easier-to-use formulation of apomorphine for Parkinson's disease, raised $63 million by offering 4.5 million shares at $14, below the most recent closing price of $14.80 (C$18.25) on the Toronto Stock Exchange. As...read more
Fitbit leads this week's 11 companies looking to raise over $1.7 billion through US initial public offerings. A good FITFitbit (FIT) flexes its muscle with the...read more
Cynapsus Therapeutics, which is developing a sublingual formulation of an approved therapy for Parkinson's disease, announced terms for its IPO on Tuesday. Cynapsus is currently listed on the Toronto Stock Exchange under the symbol CTH with a basic market...read more
US IPO Weekly Recap: 8 companies go public as Fitbit runs up 63%
Eight IPOs raised $2.3 billion this past week. High-growth consumer deals Fitbit and Fogo de Chão came out on top. This week featured a diverse set technology, consumer, energy, health care and industrial IPOs, none of which priced...read more
Cynapsus Therapeutics prices IPO at $14; Dexxon invests $10 million
Cynapsus Therapeutics, which is developing an easier-to-use formulation of apomorphine for Parkinson's disease, raised $63 million by offering 4.5 million shares at $14, below the most recent closing price of $14.80 (C$18.25) on the Toronto Stock Exchange. As...read more
Week ahead: Fitbit and 10 more IPOs planned for the week of June 15
Fitbit leads this week's 11 companies looking to raise over $1.7 billion through US initial public offerings. A good FIT Fitbit (FIT) flexes its muscle with the...read more
Under-the-tongue Parkinson's therapy: Cynapsus Therapeutics sets terms for $64 million US IPO
Cynapsus Therapeutics, which is developing a sublingual formulation of an approved therapy for Parkinson's disease, announced terms for its IPO on Tuesday. Cynapsus is currently listed on the Toronto Stock Exchange under the symbol CTH with a basic market...read more